Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.40 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | TACR2 | P21452 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29427951 | 1.00 | HSPA5 (0.53) | HSPA5TYRHTTNPC1HPGD | |
| SCHEMBL872707 | 0.94 | TYR (0.47) | HSPA5TYRHTTNPC1HPGD | |
| SCHEMBL6262361 | 0.93 | HSPA5 (0.50) | HSPA5TYRHTTALOX5PTGS2 | |
| SCHEMBL5171088 | 0.90 | NPC1 (0.52) | HSPA5TYRHTTNPC1HPGD | |
| SCHEMBL1020399 | 0.90 | EGFR (0.44) | HSPA5TYRHTTNPC1HPGD | |
| SCHEMBL1312038 | 0.90 | TYR (0.44) | HSPA5TYRHTTNPC1HPGD | |
| SCHEMBL9614548 | 0.86 | PTGS2 (0.53) | TYRHTTALOX5PTGS2EGFR | |
| SCHEMBL11673558 | 0.86 | PTGS2 (0.53) | TYRHTTALOX5PTGS2EGFR | |
| SCHEMBL28575548 | 0.86 | PTGS2 (0.53) | TYRHTTALOX5PTGS2EGFR | |
| SCHEMBL3658337 | 0.86 | TYR (0.47) | TYRHTTNPC1HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292430-A1 | COMPOSITION FOR HEAT CYCLE SYSTEM, AND HEAT CYCLE SYSTEM | AGC Inc. (JP) | 2019-09-26 | — | — | US | claimed |
| US-10364384-B2 | Composition for heat cycle system, and heat cycle system | AGC Inc. (JP) | 2019-07-30 | — | — | US | claimed |
| EP-3112438-A1 | COMPOSITION FOR HEAT CYCLE SYSTEMS, AND HEAT CYCLE SYSTEM | Asahi Glass Company, Limited (JP) | 2017-01-04 | — | — | EP | claimed |
| US-20160347980-A1 | COMPOSITION FOR HEAT CYCLE SYSTEM, AND HEAT CYCLE SYSTEM | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-12-01 | — | — | US | claimed |
| US-5639900-A | MOLYBDENUM OR TUGSTEN COMPLEXES | METTON AMERICA, INC. (US) | 1997-06-17 | — | — | US | claimed |
| US-5606085-A | PHYSICAL ACTIVATION OF TRANSITIONAL BASED COMPLEX | METTON AMERICA, INC. (US) | 1997-02-25 | — | — | US | claimed |
| US-5298471-A | Catalyst activator selected from organoaluminum, tin, silane, zinc or lead compounds | HERCULES INCORPORATED (US) | 1994-03-29 | — | — | US | claimed |
| EP-0480447-A2 | Pure tungsten oxyphenolate complexes as DCPD polymerization catalysts | HERCULES INCORPORATED (US) | 1992-04-15 | — | — | EP | claimed |
| EP-4741463-A1 | UV CURABLE COMPOSITIONS AND INKS | AGFA NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| US-12617218-B2 | Ink jet recording apparatus | SEIKO EPSON CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-3770223-B1 | INK SET AND INK JET METHOD | SEIKO EPSON CORP (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4488342-B1 | FREE RADICAL CURABLE INKJET INKS AND INKJET PRINTING METHODS | AGFA NV (BE) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092190-A1 | Radiation Curable Ink Composition For Ink Jet And Recording Apparatus | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20260092188-A1 | Radiation Curable Ink Composition For Ink Jet And Ink Jet Recording Method | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
| US-5187012-A | Saturated nonbornene polymer; antioxidant; optical recording medium | NIPPON ZEON CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| EP-0480447-A2 | Pure tungsten oxyphenolate complexes as DCPD polymerization catalysts | HERCULES INCORPORATED (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0409995-A1 | VINYLIC RESIN COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-01-30 | — | — | EP | disclosed |
| EP-0126193-B1 | BIS-(NORBORNYL OR SUBSTITUTED NORBORNYL) DERIVATIVES OF A PHENOL OR A PHENYLAMINE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME | THE DOW CHEMICAL COMPANY (US) | 1987-02-25 | — | — | EP | disclosed |
| US-4548976-A | Bis-(norbornyl or substituted norbornyl) derivatives of a phenol or a phenylamine, process for their preparation and compositions containing same | THE DOW CHEMICAL COMPANY (US) | 1985-10-22 | — | — | US | disclosed |
| EP-0126193-A1 | Bis-(norbornyl or substituted norbornyl) derivatives of a phenol or a phenylamine, process for their preparation and compositions containing same | THE DOW CHEMICAL COMPANY (US) | 1984-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092190-A1 | Radiation Curable Ink Composition For Ink Jet And Recording Apparatus | KAT8, TAS2R8, NLRP3 | HSPA5 4759/4885TYR 144/4885HTT 1141/4885 |
| US-12617218-B2 | Ink jet recording apparatus | NSD2, H1-2, H1-0 | HSPA5 3674/4885TYR 3150/4885HTT 1634/4885 |
| US-20260092188-A1 | Radiation Curable Ink Composition For Ink Jet And Ink Jet Recording Method | JAK1, EED, PI4KA | HSPA5 4478/4885TYR 975/4885HTT 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.